These trends are in line with previously described differences between primary and secondary breast angiosarcoma, in which PI3K pathway and chromatin-modifying gene alterations (such as PIK3CA and KMT2D) are more common in primary tumors [15,27]. The gene discussed is PIK3CA; the disease is breast angiosarcoma.